# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA3216010 | amodiaquine diHCl | Inhibition | = | 4.65 | % | ALA3436044 | % | Leishmania mexicana | |||
2. | ALA3216010 | amodiaquine diHCl | Inhibition | = | 2.29 | % | ALA3436043 | % | Plasmodium falciparum | |||
3. | ALA3216010 | amodiaquine diHCl | Inhibition | = | -1.88 | % | ALA3436042 | % | Homo sapiens | |||
4. | ALA3216010 | amodiaquine diHCl | DILI positive/negative | = | 1 | ALA1909323 | Source: Pfizer dataset; Commonality: consistence | |||||
5. | ALA3216010 | amodiaquine diHCl | Kinetic_solubility | > | 200 | uM | ALA2417146 | nM | ||||
6. | ALA3216010 | amodiaquine diHCl | Kinetic_solubility | > | 200 | uM | ALA2417143 | nM | ||||
7. | ALA3216010 | amodiaquine diHCl | Hepatotoxicity | 0 | ALA1697730 | DILI positive (test set) | ||||||
8. | ALA3216010 | amodiaquine diHCl | Hepatotoxicity | 0 | ALA1697722 | HH: Evidence of human hepatotoxicity | ||||||
9. | ALA3216010 | amodiaquine diHCl | IFI | = | 2.16 | % | ALA1054505 | % | ||||
10. | ALA3216010 | amodiaquine diHCl | Inhibition | = | 100 | % | ALA1054500 | % | Plasmodium falciparum | |||
11. | ALA3216010 | amodiaquine diHCl | Inhibition | = | 0 | % | ALA1054504 | % | Homo sapiens | |||
12. | ALA3216010 | amodiaquine diHCl | Inhibition | = | 3 | % | ALA1054502 | % | Plasmodium falciparum | |||
13. | ALA3216010 | amodiaquine diHCl | Inhibition | = | 99 | % | ALA1054501 | % | Plasmodium falciparum | |||
14. | ALA3216010 | amodiaquine diHCl | XC50 | = | 0.16 | uM | ALA1054503 | 6.80 | nM | Plasmodium falciparum | ||
15. | ALA3216010 | amodiaquine diHCl | IC50 | = | 4.7 | nM | ALA958383 | 8.33 | nM | Plasmodium falciparum | ||
16. | ALA3216010 | amodiaquine diHCl | Ka | = | 5.8 | 10^4/M | ALA936356 | 10^4/M | Homo sapiens | |||
17. | ALA3216010 | amodiaquine diHCl | Ka | = | 4.8 | 10^4/M | ALA936355 | 10^4/M |